STAA Q4 2023 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$76M+19.1% YoY

Gross Profit

$61M79.6% margin

Operating Income

$10M13.6% margin

Net Income

$8M10.2% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

-5.0%

Cash Flow

Operating Cash Flow

$32M

Free Cash Flow

$29M

Stock-Based Comp.

$182,000

Balance Sheet

Total Assets

$489M

Total Liabilities

$103M

Stockholders' Equity

$386M

Cash & Equivalents

$183M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$64M	+19.1%
Gross Profit	$61M	$50M	+22.0%
Operating Income	$10M	$964,000	+979.4%
Net Income	$8M	$6M	+32.5%

Revenue Segments

Implantable Collamer Lenses

$75M98%

Other Surgical Products

$2M2%